Related references
Note: Only part of the references are listed.Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection
Sunwen Chou et al.
JOURNAL OF INFECTIOUS DISEASES (2022)
Neonatal Herpes Simplex Virus Infection: Epidemiology and Outcomes in the Modern Era
Ann J. Melvin et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2022)
Antiviral therapies: advances and perspectives
Bruna Carolina Goncalves et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2021)
Benefit-risk assessment for brincidofovir for the treatment of smallpox: US Food and Drug Administration's Evaluation
Kirk Chan-Tack et al.
ANTIVIRAL RESEARCH (2021)
High conservation of varicella-zoster virus helicase-primase complex, the target of the new antiviral drug amenamevir
Marie-Liesse Pacreau et al.
ANTIVIRAL RESEARCH (2021)
Phenotype and Genotype Study of Novel C480F Maribavir-Ganciclovir Cross-Resistance Mutation Detected in Hematopoietic Stem Cell and Solid Organ Transplant Recipients
Marta Santos Bravo et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein-Barr Virus-Associated Infectious Mononucleosis
Shouyuan Zhang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2021)
Letermovir prophylaxis in solid organ transplant-Assessing CMV breakthrough and tacrolimus drug interaction
Ryan J. Winstead et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Valganciclovir-Ganciclovir Use and Systematic Therapeutic Drug Monitoring. An Invitation to Antiviral Stewardship
Alicia Galar et al.
ANTIBIOTICS-BASEL (2021)
Advances and Perspectives in the Management of Varicella-Zoster Virus Infections
Graciela Andrei et al.
MOLECULES (2021)
Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday
Guangdi Li et al.
MOLECULES (2021)
Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet
Karima Zarrouk et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Effective deploying of a novel DHODH inhibitor against herpes simplex type 1 and type 2 replication
Anna Luganini et al.
ANTIVIRAL RESEARCH (2021)
Use of pritelivir in refractory aciclovir-resistant herpes simplex virus type 2
Luke Cannon et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2021)
Small Molecules-Prospective Novel HCMV Inhibitors
Elke Bogner et al.
VIRUSES-BASEL (2021)
HCMV Antivirals and Strategies to Target the Latent Reservoir
Marianne R. Perera et al.
VIRUSES-BASEL (2021)
Assessment of Two Novel Live-Attenuated Vaccine Candidates for Herpes Simplex Virus 2 (HSV-2) in Guinea Pigs
Jonathan D. Joyce et al.
VACCINES (2021)
Letermovir in lung transplant recipients with cytomegalovirus infection: A retrospective observational study
Tobias Veit et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Characteristics of Helicase-Primase Inhibitor Amenamevir-Resistant Herpes Simplex Virus
Yuko Sato et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses
Anita Toscani et al.
MOLECULES (2021)
Pathogenesis of human cytomegalovirus in the immunocompromised host
Paul Griffiths et al.
NATURE REVIEWS MICROBIOLOGY (2021)
A helicase-primase drug candidate with sufficient target tissue exposure affects latent neural herpes simplex virus infections
Christian Gege et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Inhibition of herpes simplex virus-1 infection by MBZM-N-IBT: in silico and in vitro studies
Abhishek Kumar et al.
VIROLOGY JOURNAL (2021)
Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and-2
Lauren A. Sadowski et al.
VIRUSES-BASEL (2021)
Rational Design of Live-Attenuated Vaccines against Herpes Simplex Viruses
Brent A. Stanfield et al.
VIRUSES-BASEL (2021)
Amenamevir, a Helicase-Primase Inhibitor, for the Optimal Treatment of Herpes Zoster
Kimiyasu Shiraki et al.
VIRUSES-BASEL (2021)
Antiviral Active Compounds Derived from Natural Sources against Herpes Simplex Viruses
Lukas van de Sand et al.
VIRUSES-BASEL (2021)
Susceptibility Evaluation of Clinically Isolated HSV-1 Strains to Acyclovir: A Phenotypic and Genotypic Study
Nasrin Aliabadi et al.
JUNDISHAPUR JOURNAL OF MICROBIOLOGY (2021)
The three-component helicase/primase complex of herpes simplex virus-1
Oya Bermek et al.
OPEN BIOLOGY (2021)
Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice
Sara Scarpini et al.
VACCINES (2021)
Bactericidal and Virucidal Activities of Biogenic Metal-Based Nanoparticles: Advances and Perspectives
Gonzalo Tortella et al.
ANTIBIOTICS-BASEL (2021)
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipients
Per Ljungman et al.
ECLINICALMEDICINE (2021)
Alphaherpesvirus Vaccines
Clare Burn Aschner et al.
CURRENT ISSUES IN MOLECULAR BIOLOGY (2021)
Mechanism of resistance to acyclovir in thymidine kinase mutants from Herpes simplex virus type 1: a computational approach
Vitor Won-Held Rabelo et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients A Phase 2, Randomized Clinical Trial
Ibrahim Aldoss et al.
ANNALS OF INTERNAL MEDICINE (2020)
Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance
Sunwen Chou
ANTIVIRAL RESEARCH (2020)
The discovery and development of filociclovir for the prevention and treatment of human cytomegalovirus-related disease
Islam T. M. Hussein et al.
ANTIVIRAL RESEARCH (2020)
Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing
Helene Guermouche et al.
ANTIVIRAL RESEARCH (2020)
Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis
Jocelyne Piret et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
De Novo Genotypic Heterogeneity in the UL56 Region in Cytomegalovirus-Infected Tissues: Implications for Primary Letermovir Resistance
Horim Jo et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
The Status of Vaccine Development Against the Human Cytomegalovirus
Stanley A. Plotkin et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease
Cody S. Nelson et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections
Shiu-Jau Chen et al.
VIRUSES-BASEL (2020)
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
Morgan Hakki
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2020)
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
Hermann Einsele et al.
BLOOD (2020)
Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections
Julio J. Alvarez-Cardona et al.
FUTURE MICROBIOLOGY (2020)
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors A Randomized Clinical Trial
Nina Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Pharmaceuticals and Medical Device Agency approval summary: Amenamevir for the treatment of herpes zoster
Naoko Shoji et al.
JOURNAL OF DERMATOLOGY (2020)
Vaccines to prevent genital herpes
Kevin Egan et al.
TRANSLATIONAL RESEARCH (2020)
Human Cytomegalovirus Congenital (cCMV) Infection Following Primary and Nonprimary Maternal Infection: Perspectives of Prevention through Vaccine Development
Giuseppe Gerna et al.
VACCINES (2020)
Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects
Belen Begines et al.
NANOMATERIALS (2020)
Immune Response to Herpes Simplex Virus Infection and Vaccine Development
Anthony C. Ike et al.
VACCINES (2020)
Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses
Houssein H. Ayoub et al.
VACCINES (2020)
Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients
Vanesa Anton-Vazquez et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
Kevin P. Egan et al.
PLOS PATHOGENS (2020)
Cornus mas L. Stones: A Valuable by-Product as an Ellagitannin Source with High Antioxidant Potential
Dominika Przybylska et al.
MOLECULES (2020)
Herpesvirus Epigenetic Reprogramming and Oncogenesis
Yonggang Pei et al.
ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)
HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses
Clare Burn Aschner et al.
SCIENCE IMMUNOLOGY (2020)
Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant
Terri Lynn Shigle et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2020)
Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance
Jocelyne Piret et al.
ANTIVIRAL RESEARCH (2019)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M. Marty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
Dong H. Lee et al.
CLINICAL TRANSPLANTATION (2019)
Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient
Susanne Jung et al.
BMC INFECTIOUS DISEASES (2019)
Use of Topical Steroids in Conjunctivitis: A Review of the Evidence
Edward J. Holland et al.
CORNEA (2019)
A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection
Lesia K. Dropulic et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Fifty Years in Search of Selective Antiviral Drugs
Erik De Clercq
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Herpes Simplex Virus Evasion of Early Host Antiviral Responses
Eduardo I. Tognarelli et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Alpha-Herpesvirus Thymidine Kinase Genes Mediate Viral Virulence and Are Potential Therapeutic Targets
Ying Xie et al.
FRONTIERS IN MICROBIOLOGY (2019)
Herpes simplex virus resistant to acyclovir: A single-centre experience from the Czech Republic
Miroslav Fajfr et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2019)
Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers
Nadine G. Rouphael et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Battle between Host Immune Cellular Responses and HCMV Immune Evasion
Trishna Manandhar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Phase 1 Clinical Trial of a Conditionally Replication-Defective Human Cytomegalovirus (CMV) Vaccine in CMV-Seronegative Subjects
Stuart P. Adler et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease
David Bernstein et al.
VACCINE (2019)
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Guy El Helou et al.
INFECTION AND DRUG RESISTANCE (2019)
UL23, UL30, and UL5 characterization of HSV1 clinical strains isolated from hematology department patients
Thibault Labrunie et al.
ANTIVIRAL RESEARCH (2019)
Ganciclovir-resistant post-transplant cytomegalovirus infection due to combined deletion mutation at codons 595-596 of the UL97 gene
Po Yee Mia Leung et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
HCMV-encoded US7 and US8 act as antagonists of innate immunity by distinctively targeting TLR-signaling pathways
Areum Park et al.
NATURE COMMUNICATIONS (2019)
Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis
Nicholas Turner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax
Corinna La Rosa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
Genovefa A. Papanicolaou et al.
CLINICAL INFECTIOUS DISEASES (2019)
Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection
Sunwen Chou et al.
ANTIVIRAL RESEARCH (2019)
Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial
Janin Chandra et al.
PLOS ONE (2019)
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantation
Ilona Baraniak et al.
EBIOMEDICINE (2019)
Varicella zoster virus vaccines: an update
Giovanni Gabutti et al.
IMMUNOTARGETS AND THERAPY (2019)
Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design
Naomi R. Truong et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human cytomegalovirus vaccine development: Immune responses to look into vaccine strategy
Lin Xia et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond
Shuvam Chaudhuri et al.
ANTIVIRAL RESEARCH (2018)
Antiviral activity of maribavir in combination with other drugs active against human cytomegalovirus
Sunwen Chou et al.
ANTIVIRAL RESEARCH (2018)
Drug-resistant cytomegalovirus: clinical implications of specific mutations
Raymund R. Razonable
CURRENT OPINION IN ORGAN TRANSPLANTATION (2018)
Effects of Different Doses of GEN-003, a Therapeutic Vaccine for Genital Herpes Simplex Virus-2, on Viral Shedding and Lesions: Results of a Randomized Placebo-Controlled Trial
Nicholas Van Wagoner et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Maribavir, brincidofovir and letermovir: Efficacy and safety of new antiviral drugs for treating cytomegalovirus infections
P. Frange et al.
MEDECINE ET MALADIES INFECTIEUSES (2018)
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2018)
Multi-antigenic human cytomegalovirus mRNA vaccines that elicit potent humoral and cell-mediated immunity
Shinu John et al.
VACCINE (2018)
Antiviral Therapies for Herpesviruses: Current Agents and New Directions
Claudette L. Poole et al.
CLINICAL THERAPEUTICS (2018)
Antiviral Approaches for the Treatment of Herpes Simplex Virus Infections in Newborn Infants
Claudette L. Poole et al.
ANNUAL REVIEW OF VIROLOGY, VOL 5 (2018)
Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection
Kiyomitsu Katsumata et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector
Mark R. Schleiss et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial
Takehiko Mori et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals
Joseph Ongradi et al.
JOURNAL OF NEUROVIROLOGY (2017)
A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine alone
James M. Cleary et al.
INVESTIGATIONAL NEW DRUGS (2017)
Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades
Anja Hoffmann et al.
JOURNAL OF CLINICAL VIROLOGY (2017)
Valganciclovir for the Suppression of Epstein-Barr Virus Replication
Jessica E. Yager et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
First estimates of the global and regional incidence of neonatal herpes infection
Katharine J. Looker et al.
LANCET GLOBAL HEALTH (2017)
Comparison of Cytomegalovirus Terminase Gene Mutations Selected after Exposure to Three Distinct Inhibitor Compounds
Sunwen Chou
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2
Andreas Sauerbrei et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Potency and Stereoselectivity of Cyclopropavir Triphosphate Action on Human Cytomegalovirus DNA Polymerase
Han Chen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Novel Cytomegalovirus UL54 DNA Polymerase Gene Mutations Selected In Vitro That Confer Brincidofovir Resistance
Sunwen Chou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Novel analogs of alloferon: Synthesis, conformational studies, pro-apoptotic and antiviral activity
Mariola Kuczer et al.
BIOORGANIC CHEMISTRY (2016)
Approved Antiviral Drugs over the Past 50 Years
Erik De Clercq et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Antiviral resistance in herpes simplex virus and varicella-zoster virus infections: diagnosis and management
Jocelyne Piret et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2016)
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences A Randomized Clinical Trial
Anna Wald et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy
Paul T. Edlefsen et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals
Marine Perrier et al.
JOURNAL OF VIROLOGICAL METHODS (2016)
Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase
D. Topalis et al.
NUCLEIC ACIDS RESEARCH (2016)
Mathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes
Joshua T. Schiffer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies
Timothy K. Tippin et al.
THERAPEUTIC DRUG MONITORING (2016)
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
David I. Bernstein et al.
VACCINE (2016)
HSV antivirals - current and future treatment options
Alexander Birkmann et al.
CURRENT OPINION IN VIROLOGY (2016)
De Novo Assembly of Human Herpes Virus Type 1 (HHV-1) Genome, Mining of Non-Canonical Structures and Detection of Novel Drug-Resistance Mutations Using Short- and Long-Read Next Generation Sequencing Technologies
Timokratis Karamitros et al.
PLOS ONE (2016)
Animal herpesviruses and their zoonotic potential for cross-species infection
Grzegorz Wozniakowski et al.
ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE (2015)
Rapid In Vitro Evolution of Human Cytomegalovirus UL56 Mutations That Confer Letermovir Resistance
Sunwen Chou
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance
Susanne Schmidt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model
Marina Boukhvalova et al.
JOURNAL OF VIROLOGY (2015)
Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2
William P. Halford et al.
PLOS ONE (2015)
Ellagitannins as synergists of ACV on the replication of ACV-resistant strains of HSV 1 and 2
N. Vilhelmova-Ilieva et al.
ANTIVIRAL RESEARCH (2014)
Resistance of herpes simplex viruses to acyclovir: An update from a ten-year survey in France
Emilie Frobert et al.
ANTIVIRAL RESEARCH (2014)
Enveloped Virus-Like Particle Expression of Human Cytomegalovirus Glycoprotein B Antigen Induces Antibodies with Potent and Broad Neutralizing Activity
Marc Kirchmeier et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Blocking Herpes Simplex Virus 2 Glycoprotein E Immune Evasion as an Approach To Enhance Efficacy of a Trivalent Subunit Antigen Vaccine for Genital Herpes
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2014)
Helicase-Primase Inhibitor Pritelivir for HSV-2 Infection
Anna Wald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Prevention and management of neonatal herpes simplex virus infections
Upton D. Allen et al.
PAEDIATRICS & CHILD HEALTH (2014)
Antiviral drug resistance in herpesviruses other than cytomegalovirus
Jocelyne Piret et al.
REVIEWS IN MEDICAL VIROLOGY (2014)
Surveillance of herpes simplex virus resistance to antivirals: A 4-year survey
Sonia Burrel et al.
ANTIVIRAL RESEARCH (2013)
Phenotypic and genotypic characterization of induced acyclovir-resistant clinical isolates of herpes simplex virus type 1
Ainulkhir Hussin et al.
ANTIVIRAL RESEARCH (2013)
The DNA helicase-primase complex as a target for herpes viral infection
Sandra K. Weller et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2013)
Antiviral Medication in Sexually Transmitted Diseases. Part I: HSV, HPV
Beata Mlynarczyk-Bonikowska et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
Characterization of virus strains resistant to the herpes virus helicase-primase inhibitor ASP2151 (Amenamevir)
Koji Chono et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients
Fabio Benzi et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
ASP2151 for the Treatment of Genital Herpes: A Randomized, Double-Blind, Placebo- and Valacyclovir-Controlled, Dose-Finding Study
Stephen Tyring et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A 40-Year Journey in Search of Selective Antiviral Chemotherapy
Erik De Clercq
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management
Jocelyne Piret et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: A randomized, double-blind, placebo-controlled, patient-initiated clinical trial
Christopher M. Hull et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) Target Viral Glycoprotein-Glycosaminoglycan Interactions To Inhibit Herpes Simplex Virus 1 Entry and Cell-to-Cell Spread
Liang-Tzung Lin et al.
JOURNAL OF VIROLOGY (2011)
Genotypic Characterization of UL23 Thymidine Kinase and UL30 DNA Polymerase of Clinical Isolates of Herpes Simplex Virus: Natural Polymorphism and Mutations Associated with Resistance to Antivirals
Sonia Burrel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections
L. K. Dropulic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2
Koji Chono et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa
Esther E. Freeman et al.
VACCINE (2009)
A single drug-resistance mutation in HSV-1UL52 primase points to a difference between two helicase-primase inhibitors in their mode of interaction with the antiviral target
Subhajit Biswas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Valganciclovir for suppression of human herpesvirus-8 replication: A randomized, double-blind, placebo-controlled, crossover trial
Corey Casper et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Fluoroanalogues of anti-cytomegalovirus agent cyclopropavir: Synthesis and antiviral activity of (E)- and (Z)-9-{[2,2-bis(hydroxymethyl)-3-fluorocyclopropylidene]methyl}-adenines and guanines
Shaoman Zhou et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2007)
Human herpesvirus-6 and-7 after lung and heart-lung transplantation
Juho T. Lehto et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
N-acetylphenylisoserinates of lactarius sesquiterpenoid alcohols -: Cytotoxic, antiviral, antiproliferative and immunotropic activities in vitro
Ewa Krawczyk et al.
PLANTA MEDICA (2006)
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects
G de Bruyn et al.
VACCINE (2006)
Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet
EP Tchesnokov et al.
JOURNAL OF VIROLOGY (2006)
Understanding helicases as a means of virus control
D. N. Frick et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Resistance of human cytomegalovirus to the benzimidazole L-ribonucleoside maribavir maps UL27
G Komazin et al.
JOURNAL OF VIROLOGY (2003)
Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease
JJ Crute et al.
NATURE MEDICINE (2002)
Share Paper
